Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines

NCT01144663 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2095

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Meningococcal
Meningococcal Vaccines

Interventions

BIOLOGICAL: Nimenrix™
BIOLOGICAL: Menjugate®
BIOLOGICAL: NeisVac-CTM
BIOLOGICAL: Infanrix™ hexa
BIOLOGICAL: Synflorix™

Sponsor

GlaxoSmithKline